Tower Research Capital (TRC)’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.4K | Buy |
3,953
+2,299
| +139% | +$22.9K | ﹤0.01% | 3178 |
|
|
2025
Q1 | $9.87K | Sell |
1,654
-728
| -31% | -$4.35K | ﹤0.01% | 3712 |
|
|
2024
Q4 | $18.3K | Sell |
2,382
-2,788
| -54% | -$21.4K | ﹤0.01% | 3260 |
|
|
2024
Q3 | $52.8K | Sell |
5,170
-4,897
| -49% | -$50K | ﹤0.01% | 2694 |
|
|
2024
Q2 | $149K | Buy |
10,067
+197
| +2% | +$2.92K | ﹤0.01% | 2296 |
|
|
2024
Q1 | $135K | Sell |
9,870
-6,767
| -41% | -$92.3K | ﹤0.01% | 1660 |
|
|
2023
Q4 | $182K | Buy |
16,637
+13,989
| +528% | +$153K | ﹤0.01% | 2182 |
|
|
2023
Q3 | $29K | Buy |
2,648
+1,661
| +168% | +$18.2K | ﹤0.01% | 3052 |
|
|
2023
Q2 | $13.1K | Buy |
987
+89
| +10% | +$1.18K | ﹤0.01% | 3783 |
|
|
2023
Q1 | $12K | Buy |
898
+513
| +133% | +$6.86K | ﹤0.01% | 4089 |
|
|
2022
Q4 | $7K | Sell |
385
-10,061
| -96% | -$183K | ﹤0.01% | 4579 |
|
|
2022
Q3 | $199K | Buy |
10,446
+4,919
| +89% | +$93.7K | ﹤0.01% | 1936 |
|
|
2022
Q2 | $114K | Sell |
5,527
-328
| -6% | -$6.77K | ﹤0.01% | 2183 |
|
|
2022
Q1 | $189K | Buy |
5,855
+3,684
| +170% | +$119K | ﹤0.01% | 1772 |
|
|
2021
Q4 | $101K | Buy |
2,171
+1,608
| +286% | +$74.8K | ﹤0.01% | 2214 |
|
|
2021
Q3 | $15K | Sell |
563
-661
| -54% | -$17.6K | ﹤0.01% | 3981 |
|
|
2021
Q2 | $31K | Buy |
1,224
+21
| +2% | +$532 | ﹤0.01% | 3450 |
|
|
2021
Q1 | $41K | Buy |
1,203
+458
| +61% | +$15.6K | ﹤0.01% | 3289 |
|
|
2020
Q4 | $25K | Sell |
745
-1,234
| -62% | -$41.4K | ﹤0.01% | 3722 |
|
|
2020
Q3 | $49K | Buy |
+1,979
| New | +$49K | ﹤0.01% | 3550 |
|